Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | CES1 | P23141 | 3/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | TSHR | P16473 | 6/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1276219 | 1.00 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL716933 | 1.00 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL2838084 | 1.00 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL1261681 | 1.00 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL107823 | 1.00 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL3680616 | 1.00 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL22986932 | 1.00 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL18972927 | 1.00 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL21834650 | 1.00 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL2845989 | 1.00 | CES2 (0.50) | CES2CES1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4289860-A1 | USE OF POLYPEPTIDE COMPOUND IN PREVENTION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND INTESTINAL FIBROSIS RELATED THERETO | Shenzhen Turier Biotech Co., Ltd. (CN) | 2023-12-13 | — | — | EP | disclosed |
| US-20230312805-A1 | METHOD FOR PRODUCING HYDROXY-FATTY-ACID-BASED POLYOLS | UNIVERSITÄT BIELEFELD (DE) | 2023-10-05 | — | — | US | disclosed |
| EP-2697186-B1 | BASE OILS AND THEIR METHODS OF PRODUCTION | AMYRIS INC (US) | 2018-05-23 | — | — | EP | disclosed |
| US-9862906-B2 | Base oils and methods for making the same | Amyris, Inc. (US) | 2018-01-09 | — | — | US | disclosed |
| US-20140221258-A1 | BASE OILS AND METHODS FOR MAKING THE SAME | Amyris, Inc. (US) | 2014-08-07 | — | — | US | disclosed |
| EP-2697186-A1 | BASE OILS AND METHODS FOR MAKING THE SAME | Amyris, Inc. (US) | 2014-02-19 | — | — | EP | disclosed |
| WO-2012141784-A1 | BASE OILS AND METHODS FOR MAKING THE SAME | Amyris, Inc. (US) | 2012-10-18 | — | — | WO | disclosed |
| US-20100022692-A1 | PLASTICIZER FOR RESIN AND RESIN COMPOSITION CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| CN-101568579-A | Plasticizer for resin and resin composition containing the same | IDEMITSU KOSAN CO (JP) | 2009-10-28 | — | — | CN | disclosed |
| EP-2098563-A1 | PLASTICIZER FOR RESIN AND RESIN COMPOSITION CONTAINING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2009-09-09 | — | — | EP | disclosed |
| EP-2098563-A1 | PLASTICIZER FOR RESIN AND RESIN COMPOSITION CONTAINING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2009-09-09 | — | — | EP | disclosed |
| JP-2008156572-A | PLASTICIZER FOR RESIN AND RESIN COMPOSITION CONTAINING IT | IDEMITSU KOSAN CO LTD | 2008-07-10 | — | — | JP | disclosed |
| WO-2008078417-A1 | PLASTICIZER FOR RESIN AND RESIN COMPOSITION CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-07-03 | — | — | WO | disclosed |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-11-22 | — | — | US | disclosed |
| EP-0748823-A1 | Catalyst composition and process for the production of olefinic polymers | NIPPON OIL CO. LTD. (JP) | 1996-12-18 | — | — | EP | disclosed |
| EP-0207621-B1 | Functional polymers and their production | NIPPON PAINT CO LTD (JP) | 1995-04-05 | — | — | EP | disclosed |
| EP-0630921-A2 | Functional polymers and their production | NIPPON PAINT CO., LTD. (JP) | 1994-12-28 | — | — | EP | disclosed |
| EP-0207621-A2 | Functional polymers and their production | Nippon Paint Co., Ltd. (JP) | 1987-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221258-A1 | BASE OILS AND METHODS FOR MAKING THE SAME | OSBP, OSBPL8, FDFT1 | CES2 2640/4885CES1 1351/4885GPR84 2019/4885 |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | CARM1, CPN1, CCNT1 | CES2 500/4885CES1 611/4885GPR84 4443/4885 |
| US-20100022692-A1 | PLASTICIZER FOR RESIN AND RESIN COMPOSITION CONTAINING THE SAME | ALOX5, ALOX12, ALOX15 | CES2 712/4885CES1 1436/4885GPR84 1029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.